T. Sarvotham

Sentinel surveillance for travellers' diarrhoea in primary care

M. Evans, G. Northey, T. Sarvotham, 2007, BMC infectious diseases.

The Advocacy for Pedestrian Safety Study: Cluster Randomised Trial Evaluating a Political Advocacy Approach to Reduce Pedestrian Injuries in Deprived Communities

M. Brussoni, R. Lyons, D. Kendrick, 2013, PloS one.

Domestic and travel-related foodborne gastrointestinal illness in a population health survey

D. Thomas, M. Evans, T. Sarvotham, 2006, Epidemiology and Infection.

A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER+ HER2− Primary Breast Cancer

P. Fasching, J. Robertson, N. Harbeck, 2020, Clinical Cancer Research.

Risk factors for ciprofloxacin-resistant Campylobacter infection in Wales.

M. Evans, D. Thomas, G. Northey, 2009, The Journal of antimicrobial chemotherapy.

Short-term and medium-term clinical outcomes of quinolone-resistant Campylobacter infection.

M. Evans, Meirion R Evans, Gemma Northey, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy.

I. Garaiová, S. Plummer, M. Weaver, 2005, International journal of antimicrobial agents.

Phase I study of orally administered 14Carbon-isotope labelled-vistusertib (AZD2014), a dual TORC1/2 kinase inhibitor, to assess the absorption, metabolism, excretion, and pharmacokinetics in patients with advanced solid malignancies

D. Magirr, W. Brugger, G. Scarfe, 2019, Cancer Chemotherapy and Pharmacology.